Chemoinformaics analysis of 4-Ethoxy-4-oxobutanoic acid
| Molecular Weight | 146.142 | nRot | 4 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 2 |
| Exact Molecular Weight | 146.058 | nRing | 0 |
| Solubility: LogS | 0.029 | nHRing | 0 |
| Solubility: LogP | 0.276 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 19.8959 |
| nHD | 1 | BPOL | 13.5041 |
| QED | 0.583 |
| Synth | 1.635 |
| Natural Product Likeliness | 0.165 |
| NR-PPAR-gamma | 0.301 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -5.375 |
| MDCK | 0.00145723 |
| BBB | 0.734 |
| PPB | 0.22399 |
| VDSS | 0.218 |
| FU | 0.735843 |
| CYP1A2-inh | 0.025 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.191 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.065 |
| CL | 8.818 |
| T12 | 0.876 |
| hERG | 0.01 |
| Ames | 0.019 |
| ROA | 0.005 |
| SkinSen | 0.14 |
| Carcinogencity | 0.078 |
| EI | 0.979 |
| Respiratory | 0.027 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.964692 |